Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

HPIM Gastro > 361: Toxic and Drug-Induced Hepatitis > Flashcards

361: Toxic and Drug-Induced Hepatitis Flashcards

(81 cards)

Start Studying
1
Q

Most common cause of acute liver failure

A

Drug-induced liver injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Review: Drug metabolism

A

Drugs: water-insoluble –> water-soluble
Phase I: oxidation or methylation by cytochrome p450
Phase II : Glucuronidation or sulfation or inactivation by glutathione

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Two major types of chemical hepatotoxicity

A
  1. Direct toxic (dose-dependent)

2. Idiosyncratic (infrequent and unpredictable)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lethal dose of the toxin from Amanita phalloides that produces massive hepatic necrosis

A

10mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Drugs that cause mild, transient, nonprogressive serum aminotransferase elevation that resolve with continued drug use

A

Isoniazid
Valproate
Phenytoin
Statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Drug-induced cholestasis from mild to severe

A
  1. Bland cholestasis with limited hepatocellular injury
  2. Inflammatory cholestasis
  3. Sclerosing cholangitis
  4. Disappearance of bile ducts, “ductopenic” cholestasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Most frequently implicated antibiotic among cases of drug-induced liver injury

A

Amoxicillin-clavulanic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ratio of alanine aminotransferase (ALT) to alkaline phosphatase values the shows distinction between hepatocellular and cholestatic reaction

A

R value

if >5.0 = hepatocellular injury
if <2.0 = cholestatic injury
if 2.0-5.0 = mixed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mechanism behind the severe hepatotoxicity associated with steatohepatitis due to antiretroviral therapy with reverse transcriptase inhibitors for HIV infection

A

Mitochondrial toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

6 Mechanisms of liver injury (Figure 361-1)

A
  1. Rupture of cell membrane
  2. Injury of bile canaliculus (disruption of transport pumps)
  3. P-450-drug covalend binding (drug adducts)
  4. Drug adducts targeted by cystolytic T lymphocytes/cytokines
  5. Activation of apoptotic pathway by TNF alpha/Fas
  6. Inhibition of mitochondrial function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Major types of drug-induced hepatotoxicity with the specific drugs

A

Direct Toxic effect: Carbon tetrachloride, Acetaminophen
Idiosyncratic: Amoxicillin-clavulanate, Isoniazid, Ciprofloxacin
Others: Estrogens/Androgenic steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical drug trial named after Hyman Zimmerman that states that jaundice occurring during Phase III trial, more serious liver injury was likely, 10:1 ratio: 10 patients with jaundice to 1 patient with acute liver failure

A

“Hy’s Law”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Treatment for Toxic and Drug-Induced hepatic disease

A

Supportive except in acetaminophen hepatotoxicity

Fulminant hepatitis : Liver transplantation may be lifesaving

Withdrawal indicated at first sign of adverse reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Recommendations of these drugs for treatment:

  1. Glucocorticoids for drug hepatotoxicity with allergic features
  2. Silibinin for hepatotoxic mushroom poisoning
  3. Ursodeoxycholic acid for cholestatic drug hepatoxicity
A

NOT RECOMMENDED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drugs causing moderate to severe chronic hepatitis with autoimmune features

A
  1. Nitrofurantoin
  2. Minocycline
  3. Hydralazine
  4. Methyldopa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drugs causing cirrhosis

A
  1. Methotrexate
  2. Tamoxifen
  3. Amiodarone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Drugs causing portal hypertension in the absence of cirrhosis resulting in alteration in hepatic architecture

A
  1. Vitamin A
  2. Arsenic intoxication
  3. Industrial exposure to vinyl chloride
  4. Administration of thorium dioxide

Last 3 drugs associated with angiosarcoma of the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Effects of oral contraceptives on liver

A
  1. Hepatic adenoma
  2. Rarely = Hepatocellular carcinoma
  3. Hepatic vein occlusion (Budd-Chiari syndrome)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Unusual lesions caused by anabolic or contraceptive steroids

A

Peliosis hepatis (blood cysts of the liver)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pathology of liver injury caused by acetaminophen after single-time-point ingestions (overdose), multiple drug preparations or inappropriate drug amounts used daily for several days

A

Dose-related centrilobular hepatic necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Twice daily recommended maximum dose for acetaminophen that leads to liver failure

A

8g/d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Dose of acetaminophen that produce clinical evidence of liver injury

A

10-15g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Dose of acetaminophen that produces fatal fulminant disease

A

> /= 25g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Blood levels of acetaminophen predictive of development of severe damage

A

> 300 ug/ml 4h after ingestion

<150ug/ml: injury is unlikely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Symptoms related to time of intake of acetaminophen
4-12 h after ingestion: nausea and vomiting, diarrhea, abdominal pain, shock 24-48 h after ingestion: hepatic injury becomes apparent 3-5 days post ingestion: Maximal abnormalities and hepatic failure evident
26
Laboratory finding that increases your clinical suspicion of acetaminophen hepatotoxicity
Extremely high aminotransferase levels with low bilirubin levels
27
The antidote: safe and effective drug effective in acetaminophen hepatotoxicity
N-acetylcysteine
28
A promising diagnostic marker of acetaminophen hepatoxicity
acetaminophen-Cys adducts in serum measured by high performance liquid chromatography
29
Metabolite formed from acetaminophen under Phase I reaction that is detoxified by binding to glutathione to become a water-soluble mercapturic acid; in the absence of glutathione, binds covalently to nucleophilic hepatocyte macromolecules forming the acetaminophen-protein "adducts"
N-acetyl-p-benzoquinone-imine (NAPQI)
30
A factor associated with increased risk of acute liver injury in patients who overdose acetaminophen
Hepatitis C infection
31
FDA recommended daily dose of acetaminophen
3g (from 4g) If with opioid combination: dose should be lowered to 325mg per tablet
32
Treatment of acetaminophen overdose
1. Gastric lavage 2. Supportive measures 3. Oral administration of activated charcoal or cholestyramine to prevent absorption or residual drug (Not effective if ingestion is more than 30 mins)
33
Administration of N-acetylcysteine at what blood levels of acetaminophen reduces the severity of hepatic necrosis
>200ug/mL at 4h post ingestion OR | >100ug/mL at 8h post ingestion
34
Optimal time that therapy for acetaminophen overdose should be started
Within 8h of ingestion Partially effective if as late as 24-36h
35
Administration of N-acetylcysteine
Loading dose: 140mg/kg over 1h then 70mg/kg every 4h for 15-20 doses Treatment can be stopped when plasma acetaminophen levels indicate that risk of liver damage is LOW If with signs of hepatic faliure: liver transplantation
36
Lactate levels in acute liver failure that will distinguish patients highly likely to require liver transplantation from those likely to survive without liver replacement
lactate levels >3.5mmol/L
37
T or F: Acute renal injury occurs in 75% of patients with severe acetaminophen injury but is always self-limited
True
38
Prognosis for acute acetaminophen overdose
Survivors rarely have ongoing liver injury or sequalae
39
T or F: Elevations (ALT<200 IU/L) in serum aminotransferase levels during first few weeks of therapy of Isoniazid (INH) should warrant stopping of the drug immediately.
False. Usually self-limited and will resolve despite continued drug use
40
Latency period of acute hepatocellular drug-induced liver injury secondary to INH
Up to 6 months More frequent among alcoholics and those taking barbiturates, rifampin and pyrazinamide
41
Liver biopsy findings in INH hepatotoxicity
Morphology similar to viral hepatitis or bridging hepatic necrosis
42
T or F: | Liver injury is age-related
True Increasing after age 35, highest frequency at >50 y/o, lowest under age 20
43
T or F: | In INH hepatotoxicity: fever, rash, eosinophilia and drug allergy manifestation are unusual.
True INH produces toxic and idiosyncratic reaction
44
Most common antiepileptic drug implicated among candidates of liver transplant in children
Valproate
45
Metabolite of sodium valproate responsible for hepatic injury
4-pentenoic acid
46
Depleted compound in valproate therapy that ameliorates valproate hepatotoxicity by administration through IV
Carnitine
47
T or F: | Nitrofurantoin has a longer latency period due to its intermittent, recurrent use in cystitis among women.
True
48
T or F: Glucocorticoid and other immunosuppresants may be necessary to resolve the autoimmune injury in Nitrofurantoin hepatotoxicity.
True
49
Adverse effect seen in nitrofurantoin hepatotoxicity presenting as chronic cough and dyspnea that resolve slowly with medication withdrawal.
Interstitial pulmonary fibrosis
50
T or F: | Hepatotoxicity in amoxicillin-clavulanate can manifest during withdrawal of drug or even after.
True
51
Presentation of amoxicillin-clavulanate hepatotoxicity
Nausea, anorexia, fatigue, jaundice with pruritus Rash is uncommon
52
Amoxicillin-clavulanate causes cholestatic hepatotoxicity that can cause permanent injury to small bile ducts called
"vanishing bile duct syndrome"
53
Formerly diphenylhydantoin, mainstay treatment of seizure disorders associated with severe hepatitis-like liver injury leading to fulminant hepatic failure
Phenytoin
54
Presentation of phenytoin hepatotoxicity
Striking fever, lymphadenopathy, RASH (SJS or exfoliative dermatitis), leukocytosis, eosinophilia Duration: within 2 months of therapy
55
Metabolite of phenytoin causing hepatic injury
Arene oxides Metabolized by epoxide hydrolases
56
T or F: | In long-term phenytoin therapy, elevations of aminotransferase and alkaline phosphatase levels are usually asymptomatic
True
57
Hepatotoxicity with this antiarrhythmic drug presents with elevated aminotransferase levels with hepatomegaly
Amiodarone
58
Metabolite of Amiodarone
Desethylamiodarone
59
T or F: Elevations in aminotransferase levels in Amiodarone hepatotoxicity is dose-dependent
True
60
Condition seen on long-term recipients of Amiodarone indicating its effect on the liver
Phospholipidosis
61
T or F: | Liver injury in Amiodarone persist for months after the drug is stopped.
True Reason: Due to its long half-life
62
Most important adverse effect associated with Erythromycin seen more in children
Cholestatic reaction
63
Presentation of erythromycin hepatotoxicity
Nausea, vomiting, fever, RUQ pain, jaundice, leukocytosis, mod elevated aminotransferases and alk phosphatase. Duration: first 2 or 3 weeks of therapy
64
Prognosis of erythromycin hepatotoxicity
Symptoms subside with drug withdrawal. | No evidence of chronic liver disease on follow-up.
65
Effect of oral contraceptive combinations of estrogenic and progestational steroids on liver
Intrahepatic cholestasis
66
Presentation of oral contraceptive hepatotoxicity
Pruritus, jaundice Duration: Weeks to months after intake
67
Liver biopsy in oral contraceptive hepatotoxicity
Cholestasis with bile plugs in dilated canaliculi and striking bilirubin staining of liver cells. Portal inflammation is ABSENT.
68
Prognosis in oral contraceptive hepatotoxicity
Reversible on withdrawal
69
Contraindication of oral contraceptives on these types of patients
With history of recurrent jaundice of pregnancy
70
T or F: | Malignant neoplasm of the liver are associated with oral contraceptives
False Primarily benign, rarely malignant
71
Most common form of liver injury caused by complementary and alternative medications associated with anabolic steroids used by body builders
Profound cholestasis With NO inflammation or necrosis Duration: Weeks to months before resolution
72
Laboratories in anabolic steroid hepatotoxicity
Serum aminotransferase <100 IU/L Mod elevated alk phos Bilirubin >342 umol/L (20mg/dL)
73
Presentation of Co-trimoxazole (sulfamethoxazole) hepatotoxicity
Eosinophilia, rash, hypersensitivity reactions Self-limited Duration: Several weeks
74
T or F: Statins cause a reversible elevations (>3x) of aminotransferase activity producing a mixed hepatocellular and cholestatic reaction
True
75
Recommendation of liver test monitoring in patients treated with statins
Monitoring NOT necessary | Should not be discontinued in asymptomatic isolated aminotransferase elevations
76
Effect of Total Parenteral Nutrition (TPN) on liver
Cholestatic hepatitis Due to excess carbohydrate calories. Mechanism: Due to absence of stimulation of bile flow and secretion from lack of oral intake Intervention: Balancing TPN formula with more lipids
77
Herbal remedies associated with toxic hepatitis
1. Jin Bu Huan 2. xiao-chai-hu-tang 3. germander 4. chaparral 5. senna 6. mistletoe 7. skullcap 8. gentian 9. comfrey 10. ma huang 11. bee pollen 12. valerian root 13. pennyroyal oil 14. kava 15. herbal teas containing Camellia sinensis (green tea extract) 16. herbal nutritional supplements
78
T or F: Megadoses of vitamin A can injure the liver
True
79
Alkaloid often in Chinese herbal preparations that can cause venoocclusive injury leading to sinusoidal hepatic vein obstruction
Pyrrolizidine alkaloids
80
Emerging and common type of liver injury in HIV-infected persons
HAART therapy hepatotoxicity Zidovudine, Didanosine, stavudine Ritonavir, Indinavir Nevirapine, Efavirenz
81
Effect of HAART on liver
Hepatocellular, cholestatic and mixed

HPIM Gastro (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions